Oncology

Tecentriq improved overall survival in patients with non-small cell lung cancer.

Top news of the week in oncology, and cancer drug development.

Selumetinib did not meet trial endpoints in patients with KRASm-positive non-small cell lung cancer.

Novel drug is a bispecific T cell engager (BiTE) that targets the B-cell maturation antigen in multiple myeloma.

Underlying mechanisms of skin cancer reveal potential avenue to cure melanoma.

Expanded use of bundled payments in cancer for services such as mammography.

Physically aging a participant’s face may lead to lower long-term healthcare costs.

Combinations with hypoxia-activated prodrugs may eliminate non-small cell lung cancer tumors.

Factors other than race or ethnicity influence outcomes in multiple myeloma.

The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow, will allow pharmacists to obtain continuing education credits while staying on top of the latest oncology advances.

The toxicity of cancer drugs increasingly causing cardiovascular complications in patients.

Self-reported psychological well-being superior in patients with leukemia after a bone marrow transplant compared with peripheral blood transplants.

Some breast cancer tumors are not sensitive to Herceptin.

Duration and degree of being overweight impacts cancer risk in postmenopausal women.

Researchers examine whether cognitive impairment caused by chemotherapy drugs in breast cancer patients is a long-term issue.

Genes related to eye color may cause cancer of the eye.

Top news of the day from across the healthcare landscape.

Cancer genomics reveal genetic mutations that aid tumor growth in prostate cancer.

Treating cellular survival mechanism may prove to be a promising treatment approach for cancer.

New method able to reduce toxic side effects by avoiding use of chemotherapy.

Nanoparticle capsule to deliver experimental drug shows promise treating pancreatic cancer.

Etoposide may cause ovarian tissue damage that impacts the fertility of the unborn child.

Top news of the day from across the healthcare landscape.

Top news of the week in oncology, and cancer drug development.

Breast cancer patients who expected significant side effects from adjuvant hormone therapy reported worse adverse events.

Researchers advance understanding of how breast cancer drugs work inside human cells.

A consensus about margins could reduce healthcare costs for patients with ductal carcinoma in-situ.

Researchers have discovered a mechanism that allows cancer cells to survive without nutrients.

Hormone receptor testing may be unnecessary in breast cancer patients.

Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.